x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Jul 11, 2016 7:12 EST

Cell-IQ, LLC is a life sciences company dedicated to advanced science and research. We formulate products that unlock the body’s natural capacity for vibrant health allowing every individual to achieve wellness from within.

iCrowdNewswire - Jul 11, 2016

Cell-IQ, LLC Logo

 

 

Cell-IQ, LLC

 

 

Salt Lake City, UT 84106, US
Pharmaceuticals
www.cell-iq.com

 

 

 

Cell-IQ, LLC is a life sciences company dedicated to advanced science and research. We formulate products that unlock the body’s natural capacity for vibrant health allowing every individual to achieve wellness from within.

Given the strong, growing global demand for immunity-boosting supplements, Cell-IQ with its initial product, Immune-IQ, targets and educates mainstream consumers who seek a trustworthy, natural alternative to resolve their health related “pain points” and concerns.  Cell-IQ also targets the disenfranchised customers of comparable, but inferior immunity-boosting products, who have become disappointed in the prices and practices of their Multi Level Marketing (MLM) suppliers.

Cell-IQ markets, via its own direct marketing and Internet sales affiliates, a vastly improved version of the multi-billion dollar “Transfer Factor” (TF) immunity-enhancing dietary supplement with other breakthrough products to follow, on staggered release dates, which will boost natural energy and metabolism, respectively.

Cell-IQ leverages powerful innovations:

Disruptive Products – higher efficacy/lower cost/superior delivery of proven products.
Nimble Manufacturing – better, cheaper, faster, simpler sourcing and scaling.
Adaptive Distribution – US registration and operation, global sales and distribution.
Deep Latent Demand – tapping $1B+ un/underserved markets (virtually no competition).
Agile Finance – greater margins, lower cost of capital, greater flexibility.

As a result, Cell-IQ will provide its key stakeholders delightfully superior alternatives:

Customers will get a life-changing, immunity-boosting, “next gen” TF product, offering superior efficacy, quality, value & convenience;
Affiliate Marketers will receive the tools and channels to attract, acquire and retain up to 20 times more customers, with 20% recurring commissions for the lifetime of the customer relationship, without ongoing qualifications, for an incomparable residual income stream; and
Investors will have the opportunity to earn new venture returns on the next-gen version of a $3+B product, with a proven management team that has self-funded much of the risk capital.

 

 

Products / Services

Immune-IQ

Cell-IQ markets, via its own direct marketing and through Internet sales affiliates, a vastly improved version of the multi-billion dollar “Transfer Factor” (TF) immunity-enhancing dietary supplement, to:

Supply the $1.2B latent TF market (former customers, who value TF, but are disaffected with MLM marketing & pricing practices).
Establish and strengthen category leadership in this largely uncontested space, through strategic release of already formulated line innovations (“next gen” and “upsale” products) and line extensions (“companion” or “cross sale” products).
Begin cultivating market share in the ˜$109 B global market for immunity-enhancing supplements.

Having proven the competitive/consumer advantages of its business model, Cell-IQ will:

Deliver a succession of other products with $1B+ proven, latent demand.
Introduce new, breakthrough products (e.g., Energy-IQ and Metabolic-IQ)
Mainstream these products to the larger, global markets.

 

Management

Chief Executive Officer
David Warren

 

Chief Science/Scientist
William Hennen

 

Chief Financial Officer
Scott Eliason

 

Chief Counsel/Legal Officer
Ben Pollock

 

Chief Information Officer
Brandon Groves

 

Chief Marketing Officer
Leee Gibbons

 

 

Summary

Prior Year Revenue Current Year Revenue Next Year Revenue

 

Company Age Employees Sub-Industry
1 year, 1 month 6 Nutrition & Other Health-Related Products

 

Company Type Stock Exchange Stock Symbol
Privately-Held

 

 

 

 

 

 

Contact Information:

Scott Eliason

View Related News >
support